4 Results for "

hyperproliferative disorders

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "hyperproliferative disorders" in MCE Product Catalog:

Cat. No.: HY-145392
CAS No.: 2711039-08-4
Target:  

Acetyl-CoA synthetase

Research Areas:  

Cancer

ACSS2-IN-1 is a potent acetyl-CoA synthetase 2 (ACSS2) inhibitor with an IC50 of <1 nM. ACSS2-IN-1 inhibits ACSS2 enzymatic activity, blocks the metabolic pathway converting acetate to acetyl-CoA in cancer cells, and thereby suppresses tumor energy metabolism, lipid synthesis and histone acetylation. ACSS2-IN-1 can be used in the research of cancer and hyperproliferative disorders .
loading...
    loading...
Cat. No.: HY-112294
CAS No.: 453590-24-4
Purity:  99.91%
TIE-2/VEGFR-2 kinase-IN-1 is used for the synthesis of TIE-2 and/or VEGFR-2 inhibitors, extracted from patent WO2003022852, example 14. TIE-2/VEGFR-2 kinase-IN-1 is used for the study of diseases associated with inappropriate angiogenesis .
loading...
    loading...
Cat. No.: HY-177274
CAS No.: 182878-97-3
Target:  

Mitosis

Research Areas:  

Inflammation/Immunology

Antimitotic agent-2 (Compound 1) is an antimitotic agent. Antimitotic agent-2 inhibits the proliferation of human epidermal cells. Antimitotic agent-2 can be used in hyperproliferative skin disorders .
loading...
    loading...
Cat. No.: HY-155865
CAS No.: 2902671-74-1
Target:  

Kinesin

Research Areas:  

Cancer

CCT368772 (compound 35) is a selective kinesin HSET inhibitor (HSET ADP-Glo IC50 = 0.019 μM). CCT368772 exhibits selectivity over Eg5 (Eg5 ADP-Glo IC50 >200 μM) . CCT368772 (compound 152) can be used for the study of hyperproliferative diseases and disorders such as cancer .
loading...
    loading...